Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$8.77 - $10.85 $13,856 - $17,143
-1,580 Reduced 3.76%
40,480 $438 Million
Q3 2023

Nov 01, 2023

BUY
$9.59 - $11.35 $31,886 - $37,738
3,325 Added 8.58%
42,060 $415 Million
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $66,044 - $75,343
7,322 Added 23.31%
38,735 $387 Million
Q4 2022

Feb 14, 2023

BUY
$8.72 - $11.56 $273,921 - $363,134
31,413 New
31,413 $350 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.